SCHEMBL8083309

SCHEMBL8083309

O=C(O)CP(=O)(O)Oc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.57
USP2 O75604 1/20 0.48
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
ALOX15 P16050 1/20 0.45
ANPEP P15144 2/20 0.45
LAP3 P28838 2/20 0.45
ALDH1A1 P00352 1/20 0.44
MEN1 O00255 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28761532 0.85 SRC (0.53) SRCCYP2C9CYP2C19L3MBTL1TDP1
SCHEMBL3245338 0.83 SRC (0.61) SRCCYP2C9CYP2C19L3MBTL1TDP1
SCHEMBL27593432 0.82 SRC (0.50) SRCCYP2C9CYP2C19L3MBTL1TDP1
SCHEMBL28002420 0.82 LMNA (0.53) SRCCYP2C9CYP2C19L3MBTL1TDP1
SCHEMBL4945259 0.82 SRC (0.54) SRCUSP2CYP2C9CYP2C19L3MBTL1
SCHEMBL7826007 0.81 USP2 (0.46) SRCUSP2CYP2C9CYP2C19TDP1
SCHEMBL25698407 0.81 SRC (0.53) SRCCYP2C9CYP2C19L3MBTL1TDP1
SCHEMBL10857939 0.78 SRC (0.59) SRCCYP2C9CYP2C19L3MBTL1TDP1
SCHEMBL9583670 0.78 SRC (0.59) SRCCYP2C9CYP2C19L3MBTL1TDP1
SCHEMBL11403523 0.78 SRC (0.59) SRCCYP2C9CYP2C19L3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114466631-B Abutment of dental implant with enhanced impact dispersion function 张千石 2024-08-09 CN disclosed
EP-3241555-A1 USE OF PYROPHOSPHATE ION ANALOGUES FOR THE TREATMENT OF HPV INFECTION Agencia Pública Empresarial Sanitaria Costa Del Sol (ES) 2017-11-08 EP disclosed
EP-1030853-A1 NOVEL SIGNAL TRANSDUCTION INHIBITORS, COMPOSITIONS CONTAINING THEM ARIAD PHARMACEUTICALS, INC. (US) 2000-08-30 EP disclosed
WO-1999024442-A1 NOVEL SIGNAL TRANSDUCTION INHIBITORS, COMPOSITIONS CONTAINING THEM ARIAD PHARMACEUTICALS, INC. (US) 1999-05-20 WO disclosed
EP-0290169-A2 Diamineplatinum complexes with phosphonocarboxylate and substituted phosphonocarboxylate ligands as antitumor agents ENGELHARD CORPORATION (US) 1988-11-09 EP disclosed